File No. Official Title Country Status Filing date Filing number Publication number Grant number PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS INTERNATIONAL PROCEDURE Publication 17-Sept-02 PCT/US02/29491 WO 03/026652 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ISRAEL Filing 17-Sept-02 160693 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ICELAND Filing 17-Sept-02 7184 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS JAPAN Publication 17-Sept-02 2003-530289 2005-507889A PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS MALAYSIA Filing 20-Sept-02 PI20023503 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS MEXICO Filing 17-Sept-02 PA/A/04/002526 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS NEW ZEALAND Filing 17-Sept-02 531616 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS NORWAY Filing 17-Sept-02 20041163 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS PAKISTAN MBA Filing 21-Aug-02 736/2002 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission.
Appears in 1 contract
File No. Official Title Country Status Filing date Filing number Publication number Grant number PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS INTERNATIONAL PROCEDURE PHILIPPINES Publication 17-Sept-02 PCT/US02/29491 WO 03/026652 0-0000-000000 0-0000-000000 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ISRAEL POLAND Filing 17-Sept-02 160693 P-373299 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ICELAND PORTUGAL Filing 17-Sept-02 7184 PCT/US02/29491 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS JAPAN Publication RUSSIAN FEDERATION Filing 17-Sept-02 2003-530289 2005-507889A 0000000000 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS MALAYSIA SERBIA & MONTENEGRO Filing 2017-Sept-02 PI20023503 P227/04 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS MEXICO Filing SINGAPORE Granted 17-Sept-02 PA/A/04/002526 200401234-0 103515 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS NEW ZEALAND Filing SOUTH AFRICA Granted 17-Sept-02 531616 2004/2184 2004/2184 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS NORWAY Filing SOUTH KOREA Publication 17-Sept-02 20041163 00-0000-0000000 2004-41167 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS PAKISTAN MBA TAIWAN Filing 2110-Aug-02 736/2002 Sept-02 91120573 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission.
Appears in 1 contract
File No. Official Title Country Status Filing date Filing number Publication number Grant number PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS INTERNATIONAL PROCEDURE CHINA Publication 17-Sept-02 PCT/US02/29491 WO 03/026652 2821537 CN1578660A PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ISRAEL Filing COLOMBIA Publication 17-Sept-02 160693 4025932 567A PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ICELAND CROATIA Filing 17-Sept-02 7184 P20040280A PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS JAPAN EUROPEAN PROCEDURE (PATENTS) Publication 17-Sept-02 2003-530289 2005-507889A 2775843.2 EP1427415 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS MALAYSIA GEORGIA Filing 2017-Sept-02 PI20023503 AP2002005556 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS MEXICO Filing 17HONG KONG Publication 10-Sept-02 PA/A/04/002526 Jul-04 4105041.4 1061973A PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS NEW ZEALAND Filing HUNGARY Publication 17-Sept-02 531616 P0402463 P0402463 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS NORWAY INDIA Filing 17-Sept-02 20041163 PCT/04/00590/DEL PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS PAKISTAN MBA Filing 21INDONESIA Publication 17-Aug-02 736/2002 Sept-02 W00200400731 39.666 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission.
Appears in 1 contract
File No. Official Title Country Status Filing date Filing number Publication number Grant number PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS INTERNATIONAL PROCEDURE Publication 17THAILAND Filing 26-Sept-02 PCT/US02/29491 WO 03/026652 Aug-02 76061 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ISRAEL UKRAINE Filing 17-Sept-02 160693 20040402985 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS ICELAND Filing 17VENEZUELA Publication 20-Sept-02 7184 2002-001821 2002-001821 PH7398 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS VIETNAM Granted 17-Sept-02 0-0000-00000 5955 PH7075 NP NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS UNITED STATES OF AMERICA Granted 22-Dec-99 09/470326 6413980 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS ARMENIA Granted 17-Dec-99 200100688 4515 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS ARGENTINA Publication 20-Dec-99 990106759 1627 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS AUSTRALIA Granted 17-Dec-99 23717/00 759711 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS AUSTRIA Granted 17-Dec-99 99967444.3 EP1140941 AT280171 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS Azerbaijan Granted 17-Dec-99 200100688 4515 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission. File No. Official Title Country Status Filing date Filing number Publication number Grant number PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS BELARUS Granted 17-Dec-99 200100688 4515 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS BELGIUM Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS BRAZIL Publication 17-Dec-99 PI9917080.9 1627 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS CANADA Filing 17-Dec-99 2349330 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS CHILE Filing 17-Dec-99 3086/99 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS CROATIA Abandoned 21-Dec-99 P990396A PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS CYPRUS Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS DENMARK Granted 17-Dec-99 99967444.3 EP1140941 DK1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS EURASIAN Granted 17-Dec-99 200100688 4515 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS EUROPEAN PROCEDURE (PATENTS) Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS FINLAND Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS FRANCE Granted 17-Dec-99 99967444.3 EP1140941 1140941 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission. File No. Official Title Country Status Filing date Filing number Publication number Grant number PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS GERMANY Granted 17-Dec-99 99967444.3 EP1140941 DE69921358 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS GREECE Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS HONG KONG Publication 4-Jul-03 3104763.4 1052508A PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS INDIA MBA Filing 17-Dec-99 0587/MUM/01 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS INTERNATIONAL PROCEDURE Publication 17-Dec-99 PCT/US99/30316 WO00/39131 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS IRELAND Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS ISRAEL Filing 17-Dec-99 142959 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS ITALY Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS JAPAN Publication 17-Sept-02 2003Dec-99 591042/00 0000-530289 2005000000 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITOR KAZAKHSTAN Granted 17-507889A PH7398 LACTAMDec-99 200100688 4515 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS KYRGYZSTAN Granted 17-Dec-99 200100688 4515 PH7075 NITROGEN CONTAINING COMPOUNDS AND DERIVATIVES THEREOF HETEROBICYCLES AS FACTOR XA INHIBITORS LITHUANIA Granted 17-Dec-99 99967444.3 EP1140941 1140941 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission. File No. Official Title Country Status Filing date Filing number Publication number Grant number PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS LUXEMBOURG Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS LATVIA Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS MALAYSIA Filing 2022-Sept-02 PI20023503 PH7398 LACTAM-Dec-99 PI99005666 PH7075 NITROGEN CONTAINING COMPOUNDS AND DERIVATIVES THEREOF HETEROBICYCLES AS FACTOR XA INHIBITORS MEXICO Filing Granted 17-Sept-02 PA/A/04/002526 PH7398 LACTAMDec-99 01/006502 227521 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS MONACO Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING COMPOUNDS AND DERIVATIVES THEREOF HETEROBICYCLES AS FACTOR XA INHIBITORS MOLDOVA Granted 17-Dec-99 200100688 4515 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS NETHERLANDS Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS NEW ZEALAND Filing Granted 17-Sept-02 531616 PH7398 LACTAM-Dec-99 511674 511674 PH7075 NITROGEN CONTAINING COMPOUNDS AND DERIVATIVES THEREOF HETEROBICYCLES AS FACTOR XA INHIBITORS NORWAY Filing 17PHILIPPINES Granted 22-Sept-02 20041163 PH7398 LACTAMDec-99 1-1999-03280 0-0000-00000 PH7075 NITROGEN CONTAINING COMPOUNDS AND DERIVATIVES THEREOF HETEROBICYCLES AS FACTOR XA INHIBITORS PAKISTAN MBA PORTUGAL Granted 17-Dec-99 99967444.3 EP1140941 PT1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS ROMANIA Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS RUSSIAN FEDERATION Granted 17-Dec-99 200100688 4515 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission. File No. Official Title Country Status Filing 21date Filing number Publication number Grant number PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS SINGAPORE Granted 17-Aug-02 736/2002 Dec-99 200103293.7 81384 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS SLOVENIA Granted 17-Dec-99 99967444.3 EP1140941 SI1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS SOUTH AFRICA Granted 17-Dec-99 2001/3795 2001/3795 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS SPAIN Granted 17-Dec-99 99967444.3 EP1140941 ES2232202 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS SWEDEN Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS SWITZERLAND Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS TAIWAN Granted 15-Jan-00 88122748 NI-225862 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS TAJIKISTAN Granted 17-Dec-99 200100688 4515 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS TURKEY Granted 17-Dec-99 99967444.3 EP1140941 1140941 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS TURKMENISTAN Granted 17-Dec-99 200100688 4515 PH7075 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS UNITED KINGDOM Granted 17-Dec-99 99967444.3 EP1140941 1140941 [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission.
Appears in 1 contract
